自我效能干预对TACE联合CIK细胞治疗PLC患者生存质量的影响

doi:10.3969/j.issn.1672-5069.2018.02.045

Abstract

Li Xue, Lyu Rongde. Self-efficacy intervention in patients with primary liver cancer after TACE and CIK treatment[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 307-308.

[1] 汤钦猷. 肝癌治疗的“消灭与改造并举”策略. 实用肝脏病杂志,2015,18(2):113-114.
[2] 黄洁夫. 肝脏胆道肿瘤外科学.北京:人民卫生出版社,1999:64-66.
[3] 秦晓红. DC/CIK免疫治疗的护理. 临床护理杂志,2010,9(4):43-44.
[4] 杨葳,沈志奇.我国新型肿瘤细胞治疗方法CIK的研究与应用现状.科技导报,2008,26(6):73-77.
[5] 杨葳,徐铭宝.CIK细胞治疗恶性肿瘤研究进展.中国实用医药,2009,4(29):217-219.
[6] 马学斌,马骢.CIK细胞的基础与临床研究进展.海军总医院学报,2009,22(1):31-34.
[7] 全红铨. 自体CIK细胞同输治疗癌症的护理和健康宣教. 家庭护士,2008,6(4C):1046-1048.
[8] 滕丽莹,黄桂敏,黄秋环,等. 舒适护理对肝癌介入术后生活质量的分析. 国际护理学杂志,2013,32(7):1473.
[9] 王新歌,樊少磊,韩晗. 协同护理模式对血液透析患者自我护理能力和生活质量的影响. 中华护理杂志,2013,48(3):207-209.
[10] 高金娇,李怀富,阮国锋,等. 自我效能增强干预应用于血液透析者的效果研究. 中国实用医学,2010,5(24):168-170.
[11] 孙燕,周际昌. 临床肿瘤内科手册. 北京:人民卫生出版社,1996:53-54.
[12] Bandure A Self-efficacy:Toward a unifying theory of behavioral change. Psychol Rev,1997,84:199-215.
[13] 阮春凤. 自我效能干预对炎症性肠病患者生存质量的效果评价. 中华现代护理杂志,2010,16(17):2034-2035.
[14] Schwarzer R. Aristi B.Optimistic self-beliefs:Assessment of general peiceived self-efficacy in thirteen cultures. Word Psychol,1997,3(1-2):177-190.
[15] Zhang JX. Schwarzer R.Measuring optimistic self-beliefs:A Chinese adaptation of the general self-efficacy scale. Psychologia,1995,38(3):174-181.
[16] 李雪芬,丁玲芳.肝动脉灌注化疗栓塞治疗原发性肝细胞癌的护理.中国实用护理杂志,2010,26(27):51.

Self-efficacy intervention in patients with primary liver cancer after TACE and CIK treatment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[2]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[3]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[4]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[5]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[6]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[7]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[8]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[9]	Zhang Bangjian, Wei Shoucun, Yang Xiaoyan. Effects of dexmedetomidine combined with propofol anesthesia on perioperative stress response and postoperative recovery quality in patients undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 264-267.
[10]	Xu Dafeng, Zhou Kailun, Li Zhuori, et al.. Preliminary observation of miR-144 liposomes on inhibition of proliferation, migration and invasion of liver cancer cells in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 25-28.
[11]	Li Fang, Zou Guizhou, Gao Yufeng, et al.. Frequency of PD-1 copy number variation in individuals with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 37-40.
[12]	Wang Cuixiao, Gao Jing.. Serum Golgi protein 73, lentil lectin-reactive alpha-fetoprotein-L3,AFP andα-L- fucosidase levels in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 113-116.
[13]	Dai Xiaonan, Lyu Jinyan, Weng Wencai, et al.. Expression of IFITM3 in hepatocellular carcinoma and its correlation with intrahepatic tumor recurence after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 117-120.
[14]	Chen Xiang, Wang Baolin, Wu Chen, et al.. Efficacy of transcatheter arterial chemoembolization and radion implantation in the treatment of patients with primary liver cancer and its impact on hepatic expressions of TRF1 and TRF2 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 121-124.
[15]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.